Legal & General Group PLC Ginkgo Bioworks Holdings, Inc. Transaction History

Legal & General Group PLC

$440 Billion
Q2 2024

A detailed history of Legal & General Group PLC transactions in Ginkgo Bioworks Holdings, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 27,025,334 shares of DNA stock, worth $206 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

27,025,334

Previous 11,437,808 136.28%

Holding current value

$206 Million

Previous $13.3 Million 32.78%

% of portfolio

0.0%

Previous 0.0%

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$0.28 - $1.16 $4.36 Million - $18.1 Million	15,587,526 Added 136.28%	27,025,334 $8.92 Million
Q1 2024 May 14, 2024	BUY	$1.06 - $1.67 $10.5 Million - $16.5 Million	9,867,029 Added 628.16%	11,437,808 $13.3 Million
Q4 2023 Feb 15, 2024	BUY	$1.26 - $1.79 $18,684 - $26,543	14,829 Added 0.95%	1,570,779 $2.65 Million
Q3 2023 Nov 14, 2023	BUY	$1.61 - $2.54 $1.1 Million - $1.73 Million	682,325 Added 78.1%	1,555,950 $2.82 Million
Q2 2023 Aug 14, 2023	BUY	$1.14 - $1.95 $145,727 - $249,270	127,831 Added 17.14%	873,625 $1.62 Million
Q1 2023 May 15, 2023	BUY	$1.2 - $2.19 $31,708 - $57,868	26,424 Added 3.67%	745,794 $991,000
Q4 2022 Feb 14, 2023	BUY	$1.63 - $3.52 $216,843 - $468,276	133,033 Added 22.69%	719,370 $1.22 Million
Q3 2022 Nov 14, 2022	BUY	$0.73 - $3.74 $244,414 - $1.25 Million	334,814 Added 133.11%	586,337 $1.83 Million
Q2 2022 Aug 22, 2022	BUY	$2.2 - $4.2 $553,350 - $1.06 Million	251,523 New	251,523 $599,000

Others Institutions Holding DNA

# of Institutions

236

Shares Held

735M

Call Options Held

1.04M

Put Options Held

2.23M

View Full List

About Ginkgo Bioworks Holdings, Inc.

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $9.83B
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

More about DNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Account

Legal & General Group PLC Ginkgo Bioworks Holdings, Inc. Transaction History